Comparable on-therapy mortality and supportive care requirements in Black and White patients following initial induction for pediatric acute myeloid leukemia.
Yimei LiJoanna G NewtonKelly D GetzYuan-Shung HuangAlix E SeifBrian T FisherRichard AplencLena E WinestonePublished in: Pediatric blood & cancer (2018)
Although black patients have higher acuity at presentation and higher induction mortality, such disparities do not persist over subsequent frontline chemotherapy treatment. This finding allows interventions aimed at reducing disparities to be directed at presentation and induction.
Keyphrases
- end stage renal disease
- acute myeloid leukemia
- ejection fraction
- newly diagnosed
- chronic kidney disease
- healthcare
- peritoneal dialysis
- physical activity
- cardiovascular events
- prognostic factors
- type diabetes
- stem cells
- coronary artery disease
- quality improvement
- young adults
- patient reported
- replacement therapy
- combination therapy